Tomoyuki Hishida

Summary

Country: Japan

Publications

  1. ncbi Extraskeletal osteosarcoma arising in anterior mediastinum: brief report with a review of the literature
    Tomoyuki Hishida
    Division of Thoracic Surgery, Research Center for Innovative Oncology, National Cancer Center Hospital East, Chiba, Japan
    J Thorac Oncol 4:927-9. 2009
  2. ncbi Is surgical resection indicated for a solitary non-small cell lung cancer recurrence?
    Tomoyuki Hishida
    Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    J Thorac Cardiovasc Surg 131:838-42. 2006
  3. ncbi Problems in the current diagnostic standards of clinical N1 non-small cell lung cancer
    T Hishida
    Department of Thoracic Oncology, National Cancer Centre Hospital East, 6 5 1, Kashiwanoha, Kashiwa, Chiba, 277 8577 Japan
    Thorax 63:526-31. 2008
  4. ncbi Prognostic impact of node involvement pattern in pN1 non-small cell lung cancer patients
    Masayuki Nakao
    Division of Thoracic Surgery, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    J Thorac Oncol 5:1576-82. 2010
  5. ncbi Dynamic molecular changes associated with epithelial-mesenchymal transition and subsequent mesenchymal-epithelial transition in the early phase of metastatic tumor formation
    Keiju Aokage
    Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    Int J Cancer 128:1585-95. 2011
  6. ncbi Long-term outcome and late recurrence in patients with completely resected stage IA non-small cell lung cancer
    Ryo Maeda
    Department of Thoracic Oncology, National Cancer Center Hospital East, and daggerDepartment of Pathology, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    J Thorac Oncol 5:1246-50. 2010
  7. ncbi Risk Factors for Tumor Recurrence in Patients With Early-Stage (Stage I and II) Non-small Cell Lung Cancer: Patient Selection Criteria for Adjuvant Chemotherapy According to the Seventh Edition TNM Classification
    Ryo Maeda
    Department of Thoracic Oncology, National Cancer Center Hospital East, 6 5 1, Kashiwanoha, Kashiwa, Chiba, 277 8577, Japan
    Chest 140:1494-502. 2011
  8. ncbi Late recurrence of non-small cell lung cancer more than 5 years after complete resection: incidence and clinical implications in patient follow-up
    Ryo Maeda
    Department of Thoracic Oncology, National Cancer Center Hospital East, 6 5 1, Kashiwanoha, Kashiwa, Chiba, 277 8577, Japan
    Chest 138:145-50. 2010
  9. ncbi Prognostic impact of node involvement pattern in pulmonary pN1 squamous cell carcinoma patients
    Masayuki Nakao
    Division of Thoracic Surgery, Research Center for Innovative Oncology, National Cancer Center Hospital East, Chiba, Japan
    J Thorac Oncol 5:504-9. 2010
  10. ncbi Possible delayed cut-end recurrence after limited resection for ground-glass opacity adenocarcinoma, intraoperatively diagnosed as Noguchi type B, in three patients
    Junji Yoshida
    Department of Thoracic Oncology, National Cancer Center Hospital East, 6 5 1, Kashiwanoha, Kashiwa, Chiba 277 8577, Japan
    J Thorac Oncol 5:546-50. 2010

Collaborators

Detail Information

Publications45

  1. ncbi Extraskeletal osteosarcoma arising in anterior mediastinum: brief report with a review of the literature
    Tomoyuki Hishida
    Division of Thoracic Surgery, Research Center for Innovative Oncology, National Cancer Center Hospital East, Chiba, Japan
    J Thorac Oncol 4:927-9. 2009
    ..Complete surgical resection was successfully performed, and histologically the tumor contained osteoid formation consisting of round atypical cells. The literature concerning this rare tumor is reviewed...
  2. ncbi Is surgical resection indicated for a solitary non-small cell lung cancer recurrence?
    Tomoyuki Hishida
    Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    J Thorac Cardiovasc Surg 131:838-42. 2006
    ..Some investigators have reported long-term survival after surgical resection of a solitary non-small cell lung cancer recurrence in various sites. However, the role and indications of the second operation remain unclear...
  3. ncbi Problems in the current diagnostic standards of clinical N1 non-small cell lung cancer
    T Hishida
    Department of Thoracic Oncology, National Cancer Centre Hospital East, 6 5 1, Kashiwanoha, Kashiwa, Chiba, 277 8577 Japan
    Thorax 63:526-31. 2008
    ..One possible reason may be that cN1disease diagnosed by current standard imaging modalities often contains unexpected N2 disease. This study was conducted to evaluate the surgical and pathological results of patients with cN1 NSCLC...
  4. ncbi Prognostic impact of node involvement pattern in pN1 non-small cell lung cancer patients
    Masayuki Nakao
    Division of Thoracic Surgery, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    J Thorac Oncol 5:1576-82. 2010
    ..The purpose of this study was to evaluate the prognostic effect of node involvement patterns in pN1 non-small cell lung cancer (NSCLC) patients, with special attention given to any differences between SCC and adenocarcinoma (AD)...
  5. ncbi Dynamic molecular changes associated with epithelial-mesenchymal transition and subsequent mesenchymal-epithelial transition in the early phase of metastatic tumor formation
    Keiju Aokage
    Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    Int J Cancer 128:1585-95. 2011
    ..001) expression in comparison with cancer cells in BVBs. Our results suggested that in the early phase of metastatic tumor formation cancer cells undergo dynamic phenotypic change associated with EMT and subsequent MET...
  6. ncbi Long-term outcome and late recurrence in patients with completely resected stage IA non-small cell lung cancer
    Ryo Maeda
    Department of Thoracic Oncology, National Cancer Center Hospital East, and daggerDepartment of Pathology, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    J Thorac Oncol 5:1246-50. 2010
    ..The purpose of this study was to quantify the risk of late recurrence in patients with stage IA non-small cell lung cancer (NSCLC) who remained recurrence-free for more than 5 years after resection...
  7. ncbi Risk Factors for Tumor Recurrence in Patients With Early-Stage (Stage I and II) Non-small Cell Lung Cancer: Patient Selection Criteria for Adjuvant Chemotherapy According to the Seventh Edition TNM Classification
    Ryo Maeda
    Department of Thoracic Oncology, National Cancer Center Hospital East, 6 5 1, Kashiwanoha, Kashiwa, Chiba, 277 8577, Japan
    Chest 140:1494-502. 2011
    ..The purpose of this study was to evaluate risk factors for tumor recurrence in patients with completely resected early-stage non-small cell lung cancer (NSCLC)...
  8. ncbi Late recurrence of non-small cell lung cancer more than 5 years after complete resection: incidence and clinical implications in patient follow-up
    Ryo Maeda
    Department of Thoracic Oncology, National Cancer Center Hospital East, 6 5 1, Kashiwanoha, Kashiwa, Chiba, 277 8577, Japan
    Chest 138:145-50. 2010
    ..The purpose of this study was to evaluate the risk of late recurrence in patients who had undergone complete resection for non-small cell lung cancer (NSCLC) and remained recurrence-free for > or = 5 years...
  9. ncbi Prognostic impact of node involvement pattern in pulmonary pN1 squamous cell carcinoma patients
    Masayuki Nakao
    Division of Thoracic Surgery, Research Center for Innovative Oncology, National Cancer Center Hospital East, Chiba, Japan
    J Thorac Oncol 5:504-9. 2010
    ..The purpose of this study was to evaluate the prognostic impact of lymph node involvement patterns in pulmonary pN1 SCC patients...
  10. ncbi Possible delayed cut-end recurrence after limited resection for ground-glass opacity adenocarcinoma, intraoperatively diagnosed as Noguchi type B, in three patients
    Junji Yoshida
    Department of Thoracic Oncology, National Cancer Center Hospital East, 6 5 1, Kashiwanoha, Kashiwa, Chiba 277 8577, Japan
    J Thorac Oncol 5:546-50. 2010
    ..However, recently three of the 24 patients, with mixed GGO lesions intraoperatively diagnosed as type B, developed a solid lesion at the cut-end scar...
  11. ncbi Long-term survival and risk factors for recurrence in stage I non-small cell lung cancer patients with tumors up to 3 cm in maximum dimension
    Ryo Maeda
    Department of Thoracic Oncology, National Cancer Center Hospital East, 6 5 1 Kashiwanoha, Kashiwa, Chiba 277 8577, Japan
    Chest 138:357-62. 2010
    ....
  12. ncbi Immunohistochemical differential diagnosis between thymic carcinoma and type B3 thymoma: diagnostic utility of hypoxic marker, GLUT-1, in thymic epithelial neoplasms
    Masakazu Kojika
    Pathology Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, 6 5 1 Kashiwanoha, Kashiwa, Chiba, Japan
    Mod Pathol 22:1341-50. 2009
    ....
  13. ncbi Differences between squamous cell carcinoma and adenocarcinoma of the lung: are adenocarcinoma and squamous cell carcinoma prognostically equal?
    Akikazu Kawase
    Division of Thoracic Surgery, National Cancer Center Hospital East, Kashiwanoha, Kashiwa, Chiba, Japan
    Jpn J Clin Oncol 42:189-95. 2012
    ..We analyzed pulmonary squamous cell carcinoma and adenocarcinoma patient survival in our single institution database, to evaluate the relationship of histologic analysis to survival and tumor aggressiveness...
  14. ncbi Prognostic significance of carbonic anhydrase IX expression by cancer-associated fibroblasts in lung adenocarcinoma
    Masayuki Nakao
    Pathology Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    Cancer 115:2732-43. 2009
    ....
  15. ncbi Prognostic significance of a solid component in pulmonary adenocarcinoma
    Yoichi Ohtaki
    Division of Thoracic Surgery, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    Ann Thorac Surg 91:1051-7. 2011
    ....
  16. ncbi Influence of cigarette smoking on histological subtypes of stage I lung adenocarcinoma
    Ryo Maeda
    Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    J Thorac Oncol 6:743-50. 2011
    ..The purpose of this study was to examine the association between cigarette smoking and histological subtypes of lung adenocarcinoma...
  17. ncbi Subcarinal lymph node in upper lobe non-small cell lung cancer patients: is selective lymph node dissection valid?
    Keiju Aokage
    Division of Thoracic Surgery, National Cancer Center Hospital East, 6 5 1 Kashiwanoha, Kashiwa, Chiba 277 8577, Japan
    Lung Cancer 70:163-7. 2010
    ..It appears valid to omit subcarinal node dissection in upper lobe NSCLC patients, especially in clinical N0 squamous cell carcinoma patients...
  18. ncbi Extratumoral vascular invasion is a significant prognostic indicator and a predicting factor of distant metastasis in non-small cell lung cancer
    Yoshihisa Shimada
    Division of Thoracic Surgery, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    J Thorac Oncol 5:970-5. 2010
    ....
  19. ncbi Two lung adenocarcinomas in the same lobe: multiple primaries or intrapulmonary metastasis?
    Kentaro Yoshimoto
    Department of Thoracic Oncolog, National Cancer Center Hospital East, 6 5 1 Kashiwanoha, Kashiwa, Chiba, Japan
    Ann Thorac Cardiovasc Surg 17:584-7. 2011
    ..Although we expected EGFR gene mutation analysis would help us distinguish the 2 lesions from each other, it was of little help. Disease history can be more important in evaluating multiple pulmonary cancers...
  20. ncbi Poor prognostic factors in patients with stage IB non-small cell lung cancer according to the seventh edition TNM classification
    Ryo Maeda
    Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba 277 8577, Japan
    Chest 139:855-61. 2011
    ..This study investigated poor prognostic factors in patients with stage IB non-small cell lung cancer (NSCLC) according to the seventh edition of the TNM classification...
  21. ncbi Tumor invasion of extralobar soft tissue beyond the hilar region does not affect the prognosis of surgically resected lung cancer patients
    Hajime Otsuka
    Division of Pathology, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    J Thorac Oncol 5:1571-5. 2010
    ..The purpose of this study is to evaluate the significance of tumor invasion of that region as a prognostic factor...
  22. ncbi Visceral pleural invasion classification in non-small cell lung cancer
    Akikazu Kawase
    Division of Thoracic Surgery, National Cancer Center Hospital East, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    J Thorac Oncol 5:1784-8. 2010
    ....
  23. ncbi Histological progression of small intrapulmonary metastatic tumor from primary lung adenocarcinoma
    Keiju Aokage
    Pathology Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    Pathol Int 60:765-73. 2010
    ..These findings suggest that implanted cancer cells display lepidic growth in the early metastatic phase and recapitulate the morphological heterogeneity of the original tumor as the metastasis enlarges...
  24. ncbi Centrally located adenocarcinoma with endobronchial polypoid growth: clinicopathological analysis of five cases
    Tomoyuki Hishida
    Pathology Division, Research Center for Innovative Oncology, Department of Thoracic Oncology, National Cancer Center Hospital East, Chiba, Japan
    Pathol Int 61:73-9. 2011
    ....
  25. ncbi The prognostic impact of cigarette smoking on patients with non-small cell lung cancer
    Ryo Maeda
    Department of Thoracic Oncology, National Cancer Center Hospital East, 6 5 1 Kashiwanoha, Kashiwa, Chiba 277 8577, Japan
    J Thorac Oncol 6:735-42. 2011
    ....
  26. ncbi Stromal macrophage expressing CD204 is associated with tumor aggressiveness in lung adenocarcinoma
    Yoichi Ohtaki
    Pathology Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    J Thorac Oncol 5:1507-15. 2010
    ..Alternatively, activated macrophages (M2 phenotype) are known to be related to tumor progression and outcome, and CD204 has been reported to be expressed in M2 macrophages in some tumors...
  27. ncbi Clinicopathological characteristics of primary lung adenocarcinoma predominantly composed of goblet cells in surgically resected cases
    Hideomi Ichinokawa
    Pathology Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba
    Pathol Int 61:423-9. 2011
    ..In conclusion, APGC formed a distinct subset and should be considered separately from lung adenocarcinoma based on frequent involvement of the left and lower lung and lack of central fibrosis...
  28. ncbi The impact on survival of positive intraoperative pleural lavage cytology in patients with non-small-cell lung cancer
    Keiju Aokage
    Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    J Thorac Cardiovasc Surg 139:1246-52, 1252.e1. 2010
    ..The aim of this study was to analyze intraoperative pleural lavage cytology results in patients with non-small-cell lung cancer and quantify the impact on survival and recurrence...
  29. ncbi Late pulmonary metastasis of a rectal cancer resected 20 years after low anterior resection
    Kenji Takahashi
    Department of Thoracic Oncology, National Cancer Center Hospital East, Tokyo, Japan
    Ann Thorac Cardiovasc Surg 14:386-9. 2008
    ..This shows that pulmonary metastasis from colorectal cancer is possible even 20 years after the initial operation...
  30. ncbi Fibrous stroma is associated with poorer prognosis in lung squamous cell carcinoma patients
    Yusuke Takahashi
    Pathology Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    J Thorac Oncol 6:1460-7. 2011
    ..The aim of this study was to examine whether the histological properties of peritumoral stroma are correlated with squamous cell carcinoma (SqCC) aggressiveness and clinical outcome...
  31. ncbi Prognostic impact of histology on early-stage non-small cell lung cancer
    Ryo Maeda
    Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    Chest 140:135-45. 2011
    ..The purpose of this study is to evaluate the significance of histology as a predictor of recurrence after resection in patients with early-stage non-small cell lung cancer...
  32. ncbi Podoplanin expression by cancer associated fibroblasts predicts poor prognosis of lung adenocarcinoma
    Akikazu Kawase
    Pathology Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    Int J Cancer 123:1053-9. 2008
    ..092). The results of this study highlight the importance of podoplanin expression by CAFs and provide new insights into the biology of the cancer microenvironment in adenocarcinoma of the lung...
  33. ncbi Complete left-sided pericardial defect in a lung cancer patient undergoing pneumonectomy without closure of the defect
    Yoshihisa Shimada
    Division of Thoracic Surgery, National Cancer Center Hospital East, 6 5 1 Kashiwanoha, Kashiwa, Chiba, Japan
    Ann Thorac Cardiovasc Surg 17:67-70. 2011
    ..Complete pericardial defects usually do not endanger the lives of patients, and if the patient is asymptomatic, surgical repair of the defect may be unnecessary even during a left pneumonectomy...
  34. ncbi Expression of podoplanin, CD44, and p63 in squamous cell carcinoma of the lung
    Yoshihisa Shimada
    Pathology Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    Cancer Sci 100:2054-9. 2009
    ....
  35. ncbi Number of circulating endothelial progenitor cells and intratumoral microvessel density in non-small cell lung cancer patients: differences in angiogenic status between adenocarcinoma histologic subtypes
    Ryo Maeda
    Department of Pathology, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    J Thorac Oncol 7:503-11. 2012
    ....
  36. ncbi Prognostic impact of intratumoral vascular invasion in non-small cell lung cancer patients
    Ryo Maeda
    Department of Thoracic Oncology, National Cancer Center Hospital East, 6 5 1, Kashiwanoha, Kashiwa, Chiba 277 8577, Japan
    Thorax 65:1092-8. 2010
    ..The purpose of this study was to evaluate its significance as a risk factor for recurrence...
  37. ncbi The role of pulmonary resection in tumors metastatic from head and neck carcinomas
    Hiroyuki Daiko
    Department of Surgery, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    Jpn J Clin Oncol 40:639-44. 2010
    ..The purpose of this study was to determine the role of surgical treatment and to identify factors affecting the survival of patients undergoing pulmonary resection for tumors metastatic from head and neck carcinomas...
  38. ncbi Malignant granular cell tumor of the posterior mediastinum with dissemination
    Masayuki Nakao
    Division of Thoracic Surgery, Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    Asian Cardiovasc Thorac Ann 20:71-3. 2012
    ..Histologically, the tumor was composed of cells with large eosinophilic and granular cytoplasm, which were strongly positive for S-100. Mediastinal malignant granular cell tumor with pleural dissemination is extremely unusual...
  39. ncbi Predictive Factors of Pathologically Proven Noninvasive Tumor Characteristics in T1aN0M0 Peripheral Non-small Cell Lung Cancer
    Yoshihisa Shimada
    Division of Thoracic Surgery, National Cancer Center Hospital East, 6 5 1, Kashiwanoha, Kashiwa, Chiba 277 8577, Japan
    Chest 141:1003-9. 2012
    ....
  40. ncbi Risk factors of postoperative respiratory infections in lung cancer surgery
    Satoshi Shiono
    Division of Thoracic Surgery, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    J Thorac Oncol 2:34-8. 2007
    ..Postoperative infections have been a major issue in lung cancer surgery. We changed our perioperative prophylactic antibiotic policy to a single dose of cefazolin before and after surgery in July 2002...
  41. ncbi Multiple sclerosing hemangiomas with a 10-year history
    Tomoyuki Hishida
    Division of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba 277-8577, Japan
    Jpn J Clin Oncol 35:37-9. 2005
    ..We followed this patient by annual chest CT scans for 10 years and demonstrated that all residual nodules remained unchanged. This is the first report of stable multiple pulmonary sclerosing hemangiomas observed for such a long period...
  42. ncbi Clinical features of unresectable high-grade lung neuroendocrine carcinoma diagnosed using biopsy specimens
    Yoshihisa Shimada
    Division of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    Lung Cancer 75:368-73. 2012
    ..The aim of this study was to elucidate the clinical features of high-grade neuroendocrine carcinoma (HGNEC)-probable LCNEC diagnosed by biopsy, and compare therapeutic efficacy with patients with SCLC...
  43. ncbi Differences in clinicopathological and biological features between central-type and peripheral-type squamous cell carcinoma of the lung
    Takamoto Saijo
    Pathology Division, National Cancer Center Research Institute East, Kashiwa, Chiba, Japan
    Lung Cancer 52:37-45. 2006
    ..These results suggest that C-type and P-type SCC have different clinicopathological and biological features...
  44. ncbi Malignant glomus tumor of the lung
    Tomoyuki Hishida
    Thoracic Surgery Division, National Cancer Center Hospital, Tokyo, Japan
    Pathol Int 53:632-6. 2003
    ..We believe that this is the fourth reported case of malignant glomus tumor of the lung...
  45. ncbi Activation of the AKT and STAT3 pathways and prolonged survival by a mutant EGFR in human lung cancer cells
    Hakan Akca
    Biology Division, National Cancer Center Research Institute, Tokyo 104-0045, Japan
    Lung Cancer 54:25-33. 2006
    ..This specific property due to EGFR mutation could be an important step of multistage lung cancer progression...